Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,519.60
(
0.81%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
105.61
(
-0.15%
)
Bitcoin
81,285.18
(
0.98%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

cheynew

Send PM Follow Ignore
Followers 74
Posts 17673
Boards Moderated 0
Alias Born 09/03/2001

cheynew

Member Level

Re: jakedogman1 post# 266376

Thursday, 06/09/2016 6:23:37 AM

Thursday, June 09, 2016 6:23:37 AM

Post# of 347009
I'm still seeing it:

Not yet recruiting Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: durvalumab; Biological: bavituximab

https://www.clinicaltrials.gov/ct2/results?term=bavituximab&Search=Search
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote